| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| SAP | 123 | 41 | -14,19 % | ||
| DEUTSCHE BANK | 88 | 79 | -1,25 % | ||
| NOKIA | 42 | 34 | -9,26 % | ||
| ROCHE | 40 | 20 | +0,10 % | ||
| ASML | 38 | 26 | +0,12 % | ||
| ABB | 35 | 18 | -0,27 % | ||
| VOLKSWAGEN | 26 | 623 | +0,68 % | ||
| ING | 24 | 34 | -0,18 % | ||
| AIRBUS | 22 | 135 | -0,55 % | ||
| ADIDAS | 22 | 112 | -0,73 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02:47 | CHALCO Splashes RMB4.2B+, Partnering with Rio Tinto to Acquire Stake in Companhia Brasileira de Aluminio S.A. | 5 | AASTOCKS | ||
| 02:46 | StanChart: Bearish Oil Glut Narrative Fades as Brent Breaks $70 | 5 | OilPrice.com | ||
| 02:42 | CVC Global Sport Group To Acquire Controlling Stake In Equine Network | 1 | pulse2.com | ||
| 02:35 | Chinalco, Rio Tinto buy control of Brazilian aluminium firm CBA for $904 million | 4 | Reuters | ||
| 02:30 | Allianz SE: Pressemitteilung: Jannik Sinner und Allianz geben auf mehrere Jahre angelegte globale Partnerschaft bekannt | 184 | Business Wire | Jannik Sinner wird weltweiter Markenbotschafter der weltweit wertvollsten Versicherungsmarke. Die Partnerschaft baut die etablierten Sportkooperationen der Allianz weiter aus; die große... ► Artikel lesen | |
| 02:00 | Rio Tinto And Chalco's Joint Venture To Acquire Votorantim's Controlling Stake In CBA | 245 | AFX News | CITY OF MELBOURNE (dpa-AFX) - Rio Tinto and Aluminum Corporation of China Limited or Chalco have entered into a definitive agreement with Votorantim to acquire, through a joint venture to be... ► Artikel lesen | |
| 01:26 | UBS Reassesses Rollins (ROL) Ahead of Earnings, Maintains Neutral View | 3 | Insider Monkey | ||
| 01:26 | UBS Trims International Paper (IP) Target as Cost-Saving Efforts Continue | 2 | Insider Monkey | ||
| 01:26 | UBS Revises Scotts Miracle-Gro (SMG) Outlook as Consumer Staples Pressures Persist | 2 | Insider Monkey | ||
| 01:12 | Rio Tinto strengthens its global low-carbon aluminium footprint through joint acquisition with Chalco of Votorantim's interest in CBA | 292 | Business Wire | Rio Tinto and Aluminum Corporation of China Limited (Chalco) have entered into a definitive agreement with Votorantim (the "Transaction Agreement") to acquire, through a joint venture to be owned... ► Artikel lesen | |
| 00:56 | PRECINCT PROPERTIES NZ & PRECINCT PROPERTIES INVESTMENTS LTD: Precinct Settles Sale of InterContinental Hotel | 2 | NZX | ||
| 00:51 | Adidas meldet Rekordumsatz - Aktienrückkauf geplant | 11 | t-online.de | ||
| 00:38 | SoftBank, Ericsson Deploy AI-Powered Coverage Optimization for Massive MIMO in Japan | 4 | The Fast Mode | ||
| 00:38 | Vodafone IoT Partners with Skylo to Trial Non-Terrestrial NB-IoT Connectivity | 4 | The Fast Mode | ||
| 00:36 | Chinalco, Rio Tinto near deal to purchase Brazil's CBA - Bloomberg | 5 | Seeking Alpha | ||
| Do | BERNSTEIN RESEARCH stuft Adidas auf 'Outperform' | 941 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Adidas nach Eckdaten zum vierten Quartal auf "Outperform" mit einem Kursziel von 270 Euro belassen. Aneesha... ► Artikel lesen | |
| Do | JEFFERIES stuft Adidas auf 'Buy' | 991 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Adidas nach Eckdaten zum vierten Quartal auf "Buy" mit einem Kursziel von 220 Euro belassen. Das Stimmungsbild mit Blick... ► Artikel lesen | |
| Do | SAP outlines path to €10B free cash flow in 2026 amid rising AI-driven cloud momentum | 15 | Seeking Alpha | ||
| Do | RECORDATI ANNOUNCES STRATEGIC COLLABORATION WITH MODERNA TO DEVELOP AND COMMERCIALIZE WORLDWIDE mRNA 3927 FOR THE TREATMENT OF PROPIONIC ACIDEMIA | 238 | GlobeNewswire (Europe) | mRNA-3927 is a strong strategic fit with Recordati's rare Metabolic portfolio
Collaboration combines Moderna's expertise in mRNA technology for rare metabolic disorders with Recordati's established... ► Artikel lesen | |
| Do | Moderna partners with Recordati on rare disease therapy | 3 | Investing.com |